SHAREHOLDER ALERT: WORX GRPN SRNE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / June 22, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

SCWorx Corp. (NASDAQ:WORX)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/scworx-corp-loss-submission-form?prid=7470&wire=1
Lead Plaintiff Deadline: June 29, 2020
Class Period: April 13, 2020 – April 17, 2020

Allegations against WORX include that: (1) SCWorx's supplier for COVID-19 tests had previously misrepresented its operations; (2) SCWorx's buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) as a result, the Company's purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Groupon, Inc. (NASDAQ:GRPN)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/groupon-inc-loss-submission-form?prid=7470&wire=1
Lead Plaintiff Deadline: June 29, 2020
Class Period: November 4, 2019 – February 18, 2020

Allegations against GRPN include that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/sorrento-therapeutics-inc-loss-submission-form?prid=7470&wire=1
Lead Plaintiff Deadline: July 27, 2020
Class Period: May 15, 2020 – May 22, 2020

Allegations against SRNE include that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact, Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 594792